EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access

Predicting visual outcomes following anti-vascular endothelial growth factor treatment for diabetic macular edema

Vipin Rana, Aniruddha Agarwal, Atul Arora, Reema Bansal, Mohit Dogra, Sanjay Kumar Bhadada, Nirbhai Singh, Vishali Gupta

Indian Journal of Ophthalmology · 2024-01 · 72 (Suppl 1) · S16-S21

DOI: 10.4103/ijo.ijo_893_23 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Indian Journal of Ophthalmology, online erschienen am 22.12.2023. Verfasst von Vipin Rana und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Hauptthemen laut MEDLINE: Macular Edema, Diabetic Retinopathy, Cysts, Aneurysm. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To assess the utility of pre-defined imaging biomarkers on optical coherence tomography (OCT) and OCT angiography (OCTA) in patients with diabetic macular edema (DME) following anti-vascular endothelial growth factor (anti-VEGF) therapy in determining visual and anatomical outcomes.

Methods

In this prospective, non-randomized, and interventional study, 17 patients with treatment-naive DME were included. OCT biomarkers [size/reflectivity of cysts, disorganization of retinal inner layers, integrity of ellipsoid zone or external limiting membrane, subfoveal serous retinal detachment, hyper-reflective foci (HRF)] and OCTA [vascular density (VD), foveal avascular zone (FAZ), and total micro-aneurysms in superficial capillary plexus and deep capillary plexus (DCP)] were analyzed at baseline and after three monthly intravitreal anti-VEGF injections. Response was defined as a decrease of 10% or more in central macular thickness from the baseline after three injections.

Results

13/17 (76.47%) patients were categorized as responders to anti-VEGF therapy. Non-responders had significantly greater hyper-reflectivity of cysts ( P = 0.015), larger cystic spaces ( P = 0.023), and an increased number of HRF ( P = 0.04) at baseline. On OCTA, non-responders showed larger FAZ in DCP (1.35 ± 0.21 versus 1.14 ± 0.28 mm 2 ) ( P = 0.042) and lower VD (61.17 ± 0.45 versus 62.73 ± 3.32) in DCP at baseline. At 3 months, the VD increased in responders (63.10 ± 3.42) compared to a decrease in non-responders (60.82 ± 1.13) ( P = 0.032).

Conclusions

Non-responders show a higher number of micro-aneurysms, larger FAZ, and lower VD in the DCP on OCTA and higher cyst hyper-reflectivity and HRF and larger cystic spaces on OCT imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular EdemaDiabetic RetinopathyCystsAneurysmDiabetes MellitusHumansEndothelial Growth FactorsProspective StudiesFluorescein AngiographyRetrospective StudiesTomography, Optical CoherenceBiomarkersRetinal Vessels

Substanzen

Endothelial Growth FactorsBiomarkers

Autor:innen und Institutionen

  • Department of Ophthalmology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • The Eye Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates (UAE).
  • Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
  • Department of Ophthalmology, University of Maastricht Medical Center+, Maastricht, The Netherlands.
  • Department of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Zitieren

APA

Rana, V., Agarwal, A., Arora, A., Bansal, R., Dogra, M., Bhadada, S. K., Singh, N., & Gupta, V. (2024). Predicting visual outcomes following anti-vascular endothelial growth factor treatment for diabetic macular edema. Indian Journal of Ophthalmology, 72(Suppl 1), S16-S21. https://doi.org/10.4103/ijo.ijo_893_23

Vancouver

Rana V, Agarwal A, Arora A, Bansal R, Dogra M, Bhadada SK, et al. Predicting visual outcomes following anti-vascular endothelial growth factor treatment for diabetic macular edema. Indian Journal of Ophthalmology. 2024;72(Suppl 1):S16-S21. doi:10.4103/ijo.ijo_893_23

BibTeX
@article{Rana2024,
  author = {Rana, Vipin and Agarwal, Aniruddha and Arora, Atul and Bansal, Reema and Dogra, Mohit and Bhadada, Sanjay Kumar and Singh, Nirbhai and Gupta, Vishali},
  title = {Predicting visual outcomes following anti-vascular endothelial growth factor treatment for diabetic macular edema},
  journal = {Indian Journal of Ophthalmology},
  year = {2024},
  volume = {72},
  number = {Suppl 1},
  pages = {S16--S21},
  doi = {10.4103/ijo.ijo_893_23}
}
Kostenlos starten →